Rock Springs Capital Management LP - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 90 filers reported holding SPERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$69,421
-92.8%
57,373
-91.4%
0.00%
-91.3%
Q2 2023$970,8230.0%669,5330.0%0.02%0.0%
Q1 2023$970,823
-16.2%
669,5330.0%0.02%
-17.9%
Q4 2022$1,158,292
-24.8%
669,533
-13.1%
0.03%
-30.0%
Q3 2022$1,541,000
+169.9%
770,7100.0%0.04%
+135.3%
Q2 2022$571,000
-93.4%
770,710
-22.2%
0.02%
-92.2%
Q1 2022$8,621,000
-43.0%
990,913
+4.8%
0.22%
-38.0%
Q4 2021$15,134,000
-12.7%
945,313
+0.4%
0.35%
-3.8%
Q3 2021$17,334,000
+28.6%
941,543
-2.5%
0.36%
+36.8%
Q2 2021$13,484,000
-5.2%
965,9280.0%0.27%
-14.2%
Q1 2021$14,218,000
-40.6%
965,928
-21.8%
0.31%
-39.0%
Q4 2020$23,947,000
+73.6%
1,235,000
-0.1%
0.51%
+45.1%
Q3 2020$13,797,000
+65.8%
1,236,256
+101.0%
0.35%
+53.5%
Q2 2020$8,323,000
+70.3%
615,177
+1.7%
0.23%
+12.9%
Q1 2020$4,888,000
-3.2%
605,000
+15.2%
0.20%
+27.0%
Q4 2019$5,048,000
-9.3%
525,0000.0%0.16%
-28.4%
Q3 2019$5,565,000
-7.9%
525,0000.0%0.22%
+1.4%
Q2 2019$6,043,000
-10.1%
525,0000.0%0.22%
-15.4%
Q1 2019$6,725,000
+108.3%
525,0000.0%0.26%
+70.4%
Q4 2018$3,229,000
-41.5%
525,0000.0%0.15%
-24.0%
Q3 2018$5,518,000
-28.4%
525,0000.0%0.20%
-32.4%
Q2 2018$7,702,000
+3.0%
525,0000.0%0.30%
-7.2%
Q1 2018$7,481,000
+21.3%
525,0000.0%0.32%
+13.9%
Q4 2017$6,169,000525,0000.28%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders